Passage Bio Inc (PASG)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $13.68M
Last updated: Nov 17, 2026 at 11:06 AM ET
Passage Bio Inc (PASG) Competitors
The companies most similar to Passage Bio are Psyence Biomedical Ltd. Common Shares (PBM), Cyclerion Therapeutics (CYCN) and Biovie (BIVI). By market cap, Passage Bio ranks 7th of the 13 companies on this page; Estrella Immunopharma (ESLA) is the largest at $22.36M.
Peer Comparison
PASG's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Passage Bio (PASG) | $13.68M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Psyence Biomedical Ltd. Common Shares (PBM) | $12.00M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cyclerion Therapeutics Inc (CYCN) | $15.73M | N/A | N/A | 0.0% | N/A | -43.2% | 0.00% |
| Biovie Inc (BIVI) | $12.12M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Dare Bioscience Inc (DARE) | $12.93M | N/A | 6.4x | 0.0% | N/A | 499.6% | 0.00% |
| Phio Pharmaceuticals Corp (PHIO) | $9.21M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Biocardia Inc (BCDA) | $12.58M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Citius Pharmaceuticals Inc (CTXR) | $14.69M | N/A | 1.9x | 0.0% | -84.3% | 0.0% | 0.00% |
| In8bio Inc (INAB) | $8.86M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Context Therapeutics Inc (CNTX) | $16.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cocrystal Pharma Inc (COCP) | $18.88M | N/A | 39.2x | 0.0% | N/A | 26.9% | 0.00% |
| Pasithea Therapeutics Corp (KTTA) | $17.44M | N/A | N/A | 0.0% | N/A | 1498.0% | 0.00% |
| Estrella Immunopharma Inc. (ESLA) | $22.36M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $13.81M | N/A | 6.4x | 0.0% | -84.3% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Passage Bio, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Psyence Biomedical Ltd. Common Shares (PBM) | Psyence Biomedical Ltd. (PBM) is an innovative biotechnology company focused on harnessing the therapeutic potential of psychedelic compounds to address mental... | |
| Cyclerion Therapeutics Inc (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development... | |
| Biovie Inc (BIVI) | BioVie Inc., a clinical-stage biotechnology company, is dedicated to the discovery, development, and commercialization of drug therapies in the United States. | BIVI competitors |
| Dare Bioscience Inc (DARE) | Dar Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's health products in the United States. | DARE competitors |
| Phio Pharmaceuticals Corp (PHIO) | Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts. | PHIO competitors |
| Biocardia Inc (BCDA) | BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. | BCDA competitors |
| Citius Pharmaceuticals Inc (CTXR) | Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. | CTXR competitors |
| In8bio Inc (INAB) | IN8bio, Inc., a clinical-stage biotechnology company, is focused on developing new therapies for the treatment of cancers... | INAB competitors |
| Context Therapeutics Inc (CNTX) | Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid... | CNTX competitors |
| Cocrystal Pharma Inc (COCP) | Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic... | COCP competitors |
| Pasithea Therapeutics Corp (KTTA) | Pasithea Therapeutics Corp. The company is headquartered in Miami Beach, Florida. | KTTA competitors |
| Estrella Immunopharma Inc. (ESLA) | Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. | ESLA competitors |
Frequently Asked Questions About PASG
Who are Passage Bio's main competitors?
The companies most similar to Passage Bio include Psyence Biomedical Ltd. Common Shares (PBM), Cyclerion Therapeutics (CYCN), Biovie (BIVI), Dare Bioscience (DARE) and Phio Pharmaceuticals (PHIO), listed from the closest match.
Who is Passage Bio's biggest competitor?
Estrella Immunopharma (ESLA) is the largest of the similar companies at $22.36M; Psyence Biomedical Ltd. Common Shares (PBM) is the closest match by business profile, size, sector and industry.
How does PASG stock compare with its competitors?
PASG's net margin is 0.0% against a peer median of 0.0%.
Which of Passage Bio's competitors pays a higher dividend?
Passage Bio pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Passage Bio bigger than its competitors?
No. Passage Bio is 7th by market cap among the 13 companies on this page; the largest is Estrella Immunopharma (ESLA) at $22.36M.
PASG pages: Overview, Earnings, Forecast, Financials, Competitors